SCHEMBL22758461

SCHEMBL22758461

CCCC1(C)CCN(C(C)=O)CC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.40
TDP1 Q9NUW8 1/20 0.40
CYP2C9 P11712 5/20 0.38
CYP2D6 P10635 3/20 0.38
CYP3A4 P08684 3/20 0.38
ALDH1A1 P00352 3/20 0.38
USP2 O75604 4/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 1/20 0.38
EPHX2 P34913 1/20 0.38
PIK3CD O00329 1/20 0.37
CYP2C19 P33261 4/20 0.37
KMT2A Q03164 2/20 0.37
MAPK1 P28482 2/20 0.37
MEN1 O00255 1/20 0.37
TSHR P16473 3/20 0.36
HPGD P15428 1/20 0.34
ALOX12 P18054 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13804292 0.83 CYP1A2 (0.43) CYP1A2TDP1CYP2C9CYP2D6CYP3A4
SCHEMBL14818665 0.82 CYP1A2 (0.41) CYP1A2TDP1CYP2C9CYP2D6CYP3A4
SCHEMBL17815830 0.80 CYP1A2 (0.40) CYP1A2TDP1CYP2C9CYP2D6CYP3A4
SCHEMBL20153143 0.79 SMN1; SMN2 (0.47) CYP1A2TDP1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL14417843 0.79 CYP1A2 (0.43) CYP1A2TDP1CYP2C9CYP2D6CYP3A4
SCHEMBL13819904 0.76 SMN1; SMN2 (0.39) CYP1A2TDP1CYP2C9CYP2D6CYP3A4
SCHEMBL13819676 0.76 SMN1; SMN2 (0.39) CYP1A2TDP1CYP2C9CYP2D6CYP3A4
SCHEMBL22758462 0.75 CYP1A2 (0.53) CYP1A2CYP2C9CYP2D6CYP3A4ALDH1A1
SCHEMBL20777959 0.74 CYP4F2 (0.38) CYP1A2TDP1CYP2C9CYP2D6CYP3A4
SCHEMBL26053291 0.74 CYP1A2 (0.39) CYP1A2TDP1CYP2C9CYP2D6CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020245664-A1 N-(5-(6-ETHOXYPYRAZIN-2-YL)PYRIDIN-2-YL)-4-(2-(METHYLSULFONAMIDO)PYRIMIDIN-4-YL) TETRAHYDRO-2H-PYRAN-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS HUMAN CTPS1 INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES STEP PHARMA S.A.S. (FR) 2020-12-10 WO disclosed